Convelo Therapeutics
0 followers
Convelo Therapeutics is developing a new class of medicines that unlock the regenerative capacity of the central nervous system. Convelo is pioneering approaches to regenerate the protective myelin coating around nerve cells that is lost in a wide array of neurological diseases including multiple sc... Read more
Org chart
Derrick Rossi
President & CEO
Derrick Rossi
Collapse
Paul Tesar
Co-Founder & VP of Biology
Drew Adams
Co-Founder & VP of Discovery
Brad Lang
VP of Research, Biology Team Lead
Dan Factor
Director of Discovery, Pharmacology Team Lead
Edmond Mok
Vice President of Finance (Consultant)
Paul Tesar
Vice President of Biology
Samantha Stubblefield
VP, Operations & Program Management
Drew Adams
Convelo/Genentech Project Team Co-Lead
